Michael G. Zwick, PhD, MBAMichael G. Zwick, PhD, MBA
Dr. Zwick joined AndroBioSys in July 2007 and has a strong background in the commercialization of innovative technologies with over 17 years experience in the biotechnology industry.
He has been responsible for research and development, sales, marketing and project management in several contract research organizations and held management positions at NeoClone Biotechnology, IMMCO Diagnostics, Medic Group, Promega Corporation, and Ribozyme Pharmaceuticals (now SiRNA).
Gary J. Smith, PhD
Dr. Smith is a co-founder of the company and an expert in cancer stem cells and angiogeneisis.
He is the Co-Leader of the Prostate Program and a Distinguished Member of the Urology Department at Roswell Park Cancer Institute.
He has co-authored over 70 peer reviewed publications and together with Dr. Mohler has received over $35 million in research funding from NIH and the Department of Defense.
He has served on numerous study sections of NIH and DoD grant review panels for the past 14 years.
Read More About Dr. Gary J. Smith, PhD.
James L. Mohler, MD
Dr. Mohler is a co-founder of the company, a prostate cancer surgeon and leads an active research program in the dependence of prostate cancer.
He is Chair of the Department of Urology, Associate Director for Translational Research and Senior Vice President at Roswell Park Cancer Institute and a Professor in the Department of Urology at SUNY-Buffalo.
He and Dr. Smith have collaborated for 20 years on research programs in prostate disease.
He has co-authored over 140 peer reviewed publications and is an editor and reviewer for a number of clinical and research journals.
Read More About Dr. James L. Mohler, MD